ejoxot.wordpress.com
The stem cells, which have the ability to generate all tissue typea inthe body, pose the potential of establishinbg new cellular therapies for disease. Generating pluripotent stem cellxs from human blood either freshly collected or stored in provides a convenient sourceof patient-specific stem cellx that can be used for personalizes treatments. "The ability to use commobn tissue repositories to createiPS (induces pluripotent stem) cells from donors with known medicalo history enables us to providr the pharmaceutical industry with a cell portfolio representingg individual biology, disease models, retrospective analysis and ethnixc diversity," Emile Nuwaysir, chief operations officer of CDI.
"This is the firsty step in paving the wayfor large-scale processing and industrializatiobn of iPS cells." The findingss will be presented during a poster session beginning July 10 at the International Societyh for Stem Cell Research annual meeting in Barcelona, Cellular Dynamics International in Madison is a developer of next-generatio n stem cell technologies for drug developmengt and personalized medicine applications.
Немає коментарів:
Дописати коментар